ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)

Volume 16, 9 Issues, 2016

Download PDF Flyer

Current Cancer Drug Targets

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 73rd of 211 in Oncology

Submit Abstracts Online Submit Manuscripts Online

Ruiwen Zhang
Texas Tech University Health Sciences Center
1300 Coulter Drive
Amarillo, TX 79106

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 3.522
5 - Year: 3.572

Upcoming Articles (E-Pub Abstracts ahead of Print)

Deregulation of apoptosis – is it still an important issue in pathogenesis of chronic lymphocytic leukemia?

Monika Podhorecka, Arkadiusz Macheta, Maria Bozko, Andrzej Bozko, Nisar P. Malek and Przemyslaw Bozko.

View Abstract

Discovery of a Novel Anti-Cancer Agent Targeting Both Topoisomerase I & II as well as Telomerase Activities in Human Lung Adenocarcinoma A549 Cells In Vitro and In Vivo: Cinnamomum verum Component Cuminaldehyde

Ta-Wei Chen, Kuen-daw Tsai, Shu-mei Yang, Ho-Yiu Wong, Yi-Heng Liu, Jonathan Cherng, Kuo-Shen Chou, Yang-Tz Wang, Janise Cuizon and Jaw-Ming Cherng.

View Abstract

CYR61 contributes to poor response to letrozole in ER positive breast carcinoma

Xiaoqing Jia, Guangyu Liu, Jingyi Cheng, Zhenzhou Shen and Zhimin Shao.

View Abstract

Synthetic lethal interactions in cancer therapy

Xinwei Geng, Xiaohui Wang, Dan Zhu and Songmin Ying.

View Abstract

Targeting signaling pathways in chronic lymphocytic leukemia

Alice F. Muggen, Simar Pal Singh, Rudi W. Hendriks and Anton W Langerak.

View Abstract

Pax5 Re-Expression In H460 Cells Treated With The Combination Of Demethylating Agent And Histone Deacetylase Inhibitor Is Associated With The Enhancement Of P53 Binding To Pax5 Promoter Region

Yuanxin Liang, Jinwu Zeng, Linda Jelicks, Shengwei Ma, Jing Liu, Jingsong Mei, Roman Perez-Soler and Yiyu Zou.

View Abstract

Current Strategy for Cisplatin Delivery

Zhanguo Yue and Zhiqiang Cao.

View Abstract

E2F1 and NF-κB: Key Mediators of Inflammation-associated Cancers and Potential Therapeutic Targets

Yulin Huang, Rui Chen and Jianwei Zhou.

View Abstract

OncomicroRNAs-mediated tumorigenesis: implication in cancer diagnosis and targeted therapy

Nana Zheng, Ping Yang, Zhiwei Wang and Quansheng Zhou.

View Abstract

MT1-MMP Activation of TGF-β Signaling Enables Intercellular Activation of an Epithelial-mesenchymal Transition Program in Cancer

Hoang-Lan Nguyen, Pournima Kadam, Kevin Cao, Song Wu, Ghassan J. Samara, Qian Zhang, Stanley Zucker and Jian Cao.

View Abstract

miR-137 suppresses the phosphorylation of AKT and improves the dexamethasone sensitivity in multiple myeloma cells via targeting MITF

Benping Zhang, Ling Ma, Jia Wei, Jingyu Hu, Zichu Zhao, Youping Wang, Yan Chen and Fei Zhao.

View Abstract

BRCA1-associated triple-negative breast cancer and potential treatment for ruthenium-based compounds

Khwanjira Hongthong and Adisorn Ratanaphan.

View Abstract

Proteomic and Metabolic Signatures of Esophageal Squamous Cell Carcinoma

Kubra Karagoz, Heather L. Lehman, Douglas B. Stairs, Raghu Sinha and Kazim Y Arga.

View Abstract

Anticancer Potential and Molecular Targets of Pristimerin: A mini-review

Bashir A. Yousef, Hozeifa M. Hassan, Lu-Yong Zhang and Zhen-Zhou Jiang.

View Abstract

RBM15 functions in Blood diseases

Mengyu Hu, Yuxia Yang, Zhi Ji and Jianyuan Luo.

View Abstract

Targeted Delivery of Bleomycin: a Comprehensive Anticancer Review

Zhiqiang Yu, Bo Yan, Liqiang Gao, Chenbo Dong, Jian Zhong, Mathew D’Ortenzio, Brandon Nguyen, Xianglong Hu and Feng Liang.

View Abstract


Livia Manzella, Elena Tirrò, Maria Stella Pennisi, Michele Massimino, Stefania Stella, Chiara Romano, Silvia Rita Vitale and Paolo Vigneri.

View Abstract

nMET, a new target in recurrent cancer

Yingqiu Xie, Sholpan Istayeva, Zhanlin Chen, Tursonjan Tokay, Zhaxybay Zhumadilov, Denglong Wu, Gonzalo Hortelano and Jinfu Zhang.

View Abstract

Lactate transporters and pH regulation: potential therapeutic targets in glioblastomas

Vera Miranda-Gonçalves, Rui M. Reis and Fátima Baltazar.

View Abstract

Epi-drugs and Epi-miRs: Moving beyond current cancer therapies

Reza Salarini, Amirhossein Sahebkar, Hamid Reza Mirzaei, Mahmoud Reza Jaafari, Maryam Matbou Riahi, Jamshid Hadjati, Mobina Ostadi Asrami, Sara Fdaee, Rasoul Salehi and Hamed Mirzaei.

View Abstract

S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway

Zongliang Lu, Rui Zhou, Ya Kong, Jiajia Wang, Wanyuan Xia, Jing Guo, Jie Liu, Hailan Sun, Kai Liu, Jian Yang, Mantian Mi and Hongxia Xu.

View Abstract

Protein Geranylgeranyltransferase Type 1 as a Target in Cancer

Nisar Ullah, Muhammad Mansha and Patrick J Casey.

View Abstract

Nanoparticles for Colorectal Cancer-Targeted Drug Delivery and MR Imaging: Current Situation and Perspectives

Zhi Dong, Min-Yi Cui, Zhenpeng Peng, Yin Li, Xiaoling Wang, Zhuangnian Fang, Mengjie Jiang, Ling Xu, Yanji Luo, Zi-Ping Li and Shi-Ting Feng.

View Abstract

Peptides to Target Tumor Vasculature and Lymphatics for Improved Anti-Angiogenesis Therapy

P. R. Sivashankari and M Prabaharan.

View Abstract

MicroRNA as regulators of cancer stem cells and chemoresistance in colorectal cancer

Xiaoming Liu, Qi Fu, Yong Du, Yinxue Yang and William C Cho.

View Abstract

Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers

Felicia Fei-Lei Chung, Chun Wai Mai, Pei Yuen Ng and Chee-Onn Leong.

View Abstract

Global Biotechnology Congress 2016Drug Discovery and Therapy World Congress 2016

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2016 Bentham Science